Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rozencweig

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reviews|September 1, 1985
Carboplatin: the clinical spectrum to dateR Canetta, M Rozencweig, S K Carter
Cancer Chemotherapy and Pharmacology|January 1, 1981
Phase I clinical trial with a combination of methotrexate and mitomycin CJ J Body, M Rozencweig, Y Kenis
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Clinical implications of cisplatin pharmacologyF M Muggia, M Rozencweig, J Penta
Cancer Clinical Trials|January 1, 1979
International activities of the Division of Cancer Treatment, National Cancer InstituteA Goldin, F M Muggia, M Rozencweig
Journal of Clinical Pharmacology|August 1, 1981
Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomitingM Staquet, D Bron, M Rozencweig, et al.
Advances in Pharmacology and Chemotherapy|January 1, 1978
Daunomycin: an anthracycline antibiotic effective in acute leukemiaD D Von Hoff, M Rozencweig, M Slavik
Seminars in Oncology|March 1, 1979
Chemotherapy of testicular cancer: from palliation to curative adjuvant therapyE M Jacobs, F M Muggia, M Rozencweig
Head & Neck Surgery|January 1, 1980
Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced diseaseF M Muggia, M Rozencweig, A E Louie
Cancer Treatment Reviews|June 1, 1988
Carboplatin: current status and future prospectsR Canetta, K Bragman, L Smaldone, et al.
Seminars in Oncology|March 1, 1982
The cardiotoxicity of anticancer agentsD D Von Hoff, M Rozencweig, M Piccart
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reviews|September 1, 1985
Carboplatin: the clinical spectrum to dateR Canetta, M Rozencweig, S K Carter
Cancer Chemotherapy and Pharmacology|January 1, 1981
Phase I clinical trial with a combination of methotrexate and mitomycin CJ J Body, M Rozencweig, Y Kenis
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Clinical implications of cisplatin pharmacologyF M Muggia, M Rozencweig, J Penta
Cancer Clinical Trials|January 1, 1979
International activities of the Division of Cancer Treatment, National Cancer InstituteA Goldin, F M Muggia, M Rozencweig
Journal of Clinical Pharmacology|August 1, 1981
Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomitingM Staquet, D Bron, M Rozencweig, et al.
Advances in Pharmacology and Chemotherapy|January 1, 1978
Daunomycin: an anthracycline antibiotic effective in acute leukemiaD D Von Hoff, M Rozencweig, M Slavik
Seminars in Oncology|March 1, 1979
Chemotherapy of testicular cancer: from palliation to curative adjuvant therapyE M Jacobs, F M Muggia, M Rozencweig
Head & Neck Surgery|January 1, 1980
Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced diseaseF M Muggia, M Rozencweig, A E Louie
Cancer Treatment Reviews|June 1, 1988
Carboplatin: current status and future prospectsR Canetta, K Bragman, L Smaldone, et al.
Seminars in Oncology|March 1, 1982
The cardiotoxicity of anticancer agentsD D Von Hoff, M Rozencweig, M Piccart
Pageof 15